• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BNO 0.00% 1.0¢

BIONOMICS LIMITED - Announcements

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

Announcements


BNO Corporate Presentation November 202009/11/20 download Created with Sketch. 1.35MB
BNO Appendix 3Y26/10/20 download Created with Sketch. 162.64KB
BNO Appendix 3Y26/10/20 download Created with Sketch. 162.38KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE23/10/20 download Created with Sketch. 317.36KB
BNO Appendix 2A22/10/20 download Created with Sketch. 276.54KB
BNO Bionomics Successfully Completes Retail Entitlement OfferPRICE SENSITIVE20/10/20 download Created with Sketch. 140.57KB
BNO Bionomics Annual Report 202019/10/20 download Created with Sketch. 1.96MB
BNO Appendix 4G / Corporate Governance Statement19/10/20 download Created with Sketch. 402.15KB
BNO Notice of Annual General Meeting/Proxy Form19/10/20 download Created with Sketch. 588.97KB
BNO Bionomics Receives R&D Tax Incentive Refund of $2.9MPRICE SENSITIVE13/10/20 download Created with Sketch. 83.99KB
BNO Change in substantial holding08/10/20 download Created with Sketch. 102.26KB
BNO Appendix 2A06/10/20 download Created with Sketch. 277.98KB
BNO BNO Completes Despatch of Retail Entitlement Offer Booklet01/10/20 download Created with Sketch. 85.17KB
BNO Ineligible Shareholder Letter01/10/20 download Created with Sketch. 90.48KB
BNO Bionomics Retail Entitlement Offer BookletPRICE SENSITIVE01/10/20 download Created with Sketch. 1.96MB
BNO Update to Settlement of Institutional Entitlement Offer30/09/20 download Created with Sketch. 106.33KB
BNO BNO Successfully Completes Institutional Entitlement OfferPRICE SENSITIVE28/09/20 download Created with Sketch. 144.76KB
BNO Initial Director's Interest Notice25/09/20 download Created with Sketch. 155.58KB
BNO Initial Director's Interest Notice25/09/20 download Created with Sketch. 155.37KB
BNO Proposed issue of Securities - BNO24/09/20 download Created with Sketch. 30.11KB
BNO Appointment of Two New Directors24/09/20 download Created with Sketch. 88.13KB
BNO Equity Raising Notification to Option Holders24/09/20 download Created with Sketch. 128KB
BNO Cleansing Notice24/09/20 download Created with Sketch. 87.28KB
BNO Appendix 3B24/09/20 download Created with Sketch. 231.32KB
BNO Investor Presentation Pro Rata Entitlement OfferPRICE SENSITIVE24/09/20 download Created with Sketch. 718.8KB
BNO BNO Announces Accelerated Non-Renounceable Entitlement OfferPRICE SENSITIVE24/09/20 download Created with Sketch. 107.17KB
BNO Trading HaltPRICE SENSITIVE24/09/20 download Created with Sketch. 136.04KB
BNO FIRB Approval GrantedPRICE SENSITIVE23/09/20 download Created with Sketch. 91.8KB
BNO Change in substantial holding23/09/20 download Created with Sketch. 100.38KB
BNO Cleansing Notice Second Placement21/09/20 download Created with Sketch. 79.52KB
BNO Appendix 2A21/09/20 download Created with Sketch. 276.36KB
BNO Corporate Presentation September 202016/09/20 download Created with Sketch. 1.53MB
BNO Clinical Program Updates15/09/20 download Created with Sketch. 101.85KB
BNO Presentation at H.C. Wainwright Global Investment Conference09/09/20 download Created with Sketch. 90.12KB
BNO Change of Director's Interest Notice01/09/20 download Created with Sketch. 162.45KB
BNO Full Year Statutory Accounts28/08/20 download Created with Sketch. 1.11MB
BNO 2019/2020 Preliminary Final ReportPRICE SENSITIVE28/08/20 download Created with Sketch. 182.36KB
BNO Appendix 3G28/08/20 download Created with Sketch. 278.79KB
BNO Appendix 2A28/08/20 download Created with Sketch. 280.69KB
BNO Response to ASX Price QueryPRICE SENSITIVE27/08/20 download Created with Sketch. 267.47KB
BNO Results of General Meeting26/08/20 download Created with Sketch. 102.36KB
BNO Response to ASX Price QueryPRICE SENSITIVE17/08/20 download Created with Sketch. 682.4KB
BNO Date of 2020 Annual General Meeting07/08/20 download Created with Sketch. 25.67KB
BNO Lapse of Employee Share Options07/08/20 download Created with Sketch. 79.68KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 383.17KB
BNO Notice of General Meeting/Proxy Form24/07/20 download Created with Sketch. 2.11MB
BNO Restatement of AccountsPRICE SENSITIVE21/07/20 download Created with Sketch. 116.95KB
BNO Initial Director's Interest Notice03/07/20 download Created with Sketch. 151.32KB
BNO Appointment of New Director - Mr Aaron Weaver03/07/20 download Created with Sketch. 117.97KB
BNO Change in substantial holding02/07/20 download Created with Sketch. 88KB
BNO Becoming a substantial holder01/07/20 download Created with Sketch. 1.85MB
BNO Lapse of Employee Share Options01/07/20 download Created with Sketch. 80.83KB
BNO Appendix 2A30/06/20 download Created with Sketch. 276.43KB
BNO Cleansing Notice30/06/20 download Created with Sketch. 76.96KB
BNO Executive Chairman - New Consultancy Agreement22/06/20 download Created with Sketch. 127.87KB
BNO Proposed issue of Securities - BNO02/06/20 download Created with Sketch. 25.2KB
BNO Recapitalisation Led by Apeiron Investment Group LtdPRICE SENSITIVE02/06/20 download Created with Sketch. 136.13KB
BNO BNO Extends Cash Runway Through Deferral of Loan RepaymentsPRICE SENSITIVE11/05/20 download Created with Sketch. 90.85KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE23/04/20 download Created with Sketch. 362.26KB
BNO Recruitment Completed in Phase 2 BNC105 / Nivolumab Trial15/04/20 download Created with Sketch. 171.03KB
BNO Published BNC210 Phase 2b Data, Additional InformationPRICE SENSITIVE03/04/20 download Created with Sketch. 191.39KB
BNO Positive Phase 2b Data for BNC210 in GAD Patients PublishedPRICE SENSITIVE02/04/20 download Created with Sketch. 131.1KB
BNO Completion of Sale of Bionomics' French SubsidiariesPRICE SENSITIVE03/03/20 download Created with Sketch. 117.55KB
BNO Half Yearly Report and AccountsPRICE SENSITIVE28/02/20 download Created with Sketch. 557.33KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE30/01/20 download Created with Sketch. 359.22KB
BNO Bionomics Corporate PresentationPRICE SENSITIVE29/01/20 download Created with Sketch. 1.03MB
BNO Lapse of Unlisted Employee Share Options and Warrant19/12/19 download Created with Sketch. 412.01KB
BNO Sale of French Subsidiaries to Domain TherapeuticsPRICE SENSITIVE11/12/19 download Created with Sketch. 118.67KB
BNO Results of Meeting20/11/19 download Created with Sketch. 97.14KB
BNO Planned Recruitment of New CEOPRICE SENSITIVE20/11/19 download Created with Sketch. 123.75KB
BNO Executive Chairman's 2019 AGM PresentationPRICE SENSITIVE20/11/19 download Created with Sketch. 1.03MB
BNO Bionomics Receives R&D Tax Incentive Refund of $5.1MPRICE SENSITIVE11/11/19 download Created with Sketch. 79.96KB
BNO FDA Grants Fast Track Designation to BNC210 PTSD ProgramPRICE SENSITIVE04/11/19 download Created with Sketch. 91.11KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE28/10/19 download Created with Sketch. 563.09KB
BNO Appendix 4G / Corporate Governance Statement18/10/19 download Created with Sketch. 447.07KB
BNO Bionomics Annual Report 201918/10/19 download Created with Sketch. 2.21MB
BNO Notice of Annual General Meeting/Proxy Form18/10/19 download Created with Sketch. 1.39MB
BNO BNC210 Solid Dose Achieves Required Blood LevelsPRICE SENSITIVE26/09/19 download Created with Sketch. 91.93KB
BNO BNO - FDA Fast Track ApplicationPRICE SENSITIVE19/09/19 download Created with Sketch. 84.66KB
BNO Date of 2019 Annual General Meeting30/08/19 download Created with Sketch. 25.77KB
BNO Full Year Statutory Accounts20/08/19 download Created with Sketch. 1.27MB
BNO Bionomics 2018/2019 Preliminary Final ResultsPRICE SENSITIVE20/08/19 download Created with Sketch. 178.41KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 350.71KB
BNO Bionomics Receives Further R&D Tax Incentive Refund of $1.3MPRICE SENSITIVE22/07/19 download Created with Sketch. 81.14KB
BNO Appendix 3B12/07/19 download Created with Sketch. 408.75KB
BNO Executive Chairman Extension of Appointment28/06/19 download Created with Sketch. 118.36KB
BNO Presentation - BNC210 UpdatePRICE SENSITIVE26/06/19 download Created with Sketch. 612.31KB
BNO Results of BNC210 Agitation TrialPRICE SENSITIVE26/06/19 download Created with Sketch. 197.33KB
BNO Trading HaltPRICE SENSITIVE24/06/19 download Created with Sketch. 140.29KB
BNO Appendix 3B21/06/19 download Created with Sketch. 407.81KB
BNO Ceasing to be a substantial holder13/06/19 download Created with Sketch. 180.26KB
BNO BNC375 Medicinal Chemistry Paper Published05/06/19 download Created with Sketch. 114KB
BNO Strategic Review Outcome and Program UpdatesPRICE SENSITIVE29/05/19 download Created with Sketch. 106.63KB
BNO Results of the PTSD Trial and Exposure Analyses Presented16/05/19 download Created with Sketch. 94.36KB
BNO Appendix 4C - quarterlyPRICE SENSITIVE30/04/19 download Created with Sketch. 344.66KB
BNO Executive Chairman Extension of Appointment15/03/19 download Created with Sketch. 103.47KB
BNO S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19 download Created with Sketch. 175.31KB
BNO Further Analysis of Phase 2 PTSD Trial Results PresentationPRICE SENSITIVE18/02/19 download Created with Sketch. 690.3KB
BNO Further Analysis of Phase 2 PTSD ResultsPRICE SENSITIVE18/02/19 download Created with Sketch. 136.22KB
BNO Half Yearly Report and AccountsPRICE SENSITIVE15/02/19 download Created with Sketch. 497.57KB
BNO Corporate Presentation November 2020
09/11/20 download Created with Sketch. 1.35MB
BNO Appendix 3Y
26/10/20 download Created with Sketch. 162.64KB
BNO Appendix 3Y
26/10/20 download Created with Sketch. 162.38KB
BNO Appendix 4C - quarterly
23/10/20PRICE SENSITIVE download Created with Sketch. 317.36KB
BNO Appendix 2A
22/10/20 download Created with Sketch. 276.54KB
BNO Bionomics Successfully Completes Retail Entitlement Offer
20/10/20PRICE SENSITIVE download Created with Sketch. 140.57KB
BNO Bionomics Annual Report 2020
19/10/20 download Created with Sketch. 1.96MB
BNO Appendix 4G / Corporate Governance Statement
19/10/20 download Created with Sketch. 402.15KB
BNO Notice of Annual General Meeting/Proxy Form
19/10/20 download Created with Sketch. 588.97KB
BNO Bionomics Receives R&D Tax Incentive Refund of $2.9M
13/10/20PRICE SENSITIVE download Created with Sketch. 83.99KB
BNO Change in substantial holding
08/10/20 download Created with Sketch. 102.26KB
BNO Appendix 2A
06/10/20 download Created with Sketch. 277.98KB
BNO BNO Completes Despatch of Retail Entitlement Offer Booklet
01/10/20 download Created with Sketch. 85.17KB
BNO Ineligible Shareholder Letter
01/10/20 download Created with Sketch. 90.48KB
BNO Bionomics Retail Entitlement Offer Booklet
01/10/20PRICE SENSITIVE download Created with Sketch. 1.96MB
BNO Update to Settlement of Institutional Entitlement Offer
30/09/20 download Created with Sketch. 106.33KB
BNO BNO Successfully Completes Institutional Entitlement Offer
28/09/20PRICE SENSITIVE download Created with Sketch. 144.76KB
BNO Initial Director's Interest Notice
25/09/20 download Created with Sketch. 155.58KB
BNO Initial Director's Interest Notice
25/09/20 download Created with Sketch. 155.37KB
BNO Proposed issue of Securities - BNO
24/09/20 download Created with Sketch. 30.11KB
BNO Appointment of Two New Directors
24/09/20 download Created with Sketch. 88.13KB
BNO Equity Raising Notification to Option Holders
24/09/20 download Created with Sketch. 128KB
BNO Cleansing Notice
24/09/20 download Created with Sketch. 87.28KB
BNO Appendix 3B
24/09/20 download Created with Sketch. 231.32KB
BNO Investor Presentation Pro Rata Entitlement Offer
24/09/20PRICE SENSITIVE download Created with Sketch. 718.8KB
BNO BNO Announces Accelerated Non-Renounceable Entitlement Offer
24/09/20PRICE SENSITIVE download Created with Sketch. 107.17KB
BNO Trading Halt
24/09/20PRICE SENSITIVE download Created with Sketch. 136.04KB
BNO FIRB Approval Granted
23/09/20PRICE SENSITIVE download Created with Sketch. 91.8KB
BNO Change in substantial holding
23/09/20 download Created with Sketch. 100.38KB
BNO Cleansing Notice Second Placement
21/09/20 download Created with Sketch. 79.52KB
BNO Appendix 2A
21/09/20 download Created with Sketch. 276.36KB
BNO Corporate Presentation September 2020
16/09/20 download Created with Sketch. 1.53MB
BNO Clinical Program Updates
15/09/20 download Created with Sketch. 101.85KB
BNO Presentation at H.C. Wainwright Global Investment Conference
09/09/20 download Created with Sketch. 90.12KB
BNO Change of Director's Interest Notice
01/09/20 download Created with Sketch. 162.45KB
BNO Full Year Statutory Accounts
28/08/20 download Created with Sketch. 1.11MB
BNO 2019/2020 Preliminary Final Report
28/08/20PRICE SENSITIVE download Created with Sketch. 182.36KB
BNO Appendix 3G
28/08/20 download Created with Sketch. 278.79KB
BNO Appendix 2A
28/08/20 download Created with Sketch. 280.69KB
BNO Response to ASX Price Query
27/08/20PRICE SENSITIVE download Created with Sketch. 267.47KB
BNO Results of General Meeting
26/08/20 download Created with Sketch. 102.36KB
BNO Response to ASX Price Query
17/08/20PRICE SENSITIVE download Created with Sketch. 682.4KB
BNO Date of 2020 Annual General Meeting
07/08/20 download Created with Sketch. 25.67KB
BNO Lapse of Employee Share Options
07/08/20 download Created with Sketch. 79.68KB
BNO Appendix 4C - quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 383.17KB
BNO Notice of General Meeting/Proxy Form
24/07/20 download Created with Sketch. 2.11MB
BNO Restatement of Accounts
21/07/20PRICE SENSITIVE download Created with Sketch. 116.95KB
BNO Initial Director's Interest Notice
03/07/20 download Created with Sketch. 151.32KB
BNO Appointment of New Director - Mr Aaron Weaver
03/07/20 download Created with Sketch. 117.97KB
BNO Change in substantial holding
02/07/20 download Created with Sketch. 88KB
BNO Becoming a substantial holder
01/07/20 download Created with Sketch. 1.85MB
BNO Lapse of Employee Share Options
01/07/20 download Created with Sketch. 80.83KB
BNO Appendix 2A
30/06/20 download Created with Sketch. 276.43KB
BNO Cleansing Notice
30/06/20 download Created with Sketch. 76.96KB
BNO Executive Chairman - New Consultancy Agreement
22/06/20 download Created with Sketch. 127.87KB
BNO Proposed issue of Securities - BNO
02/06/20 download Created with Sketch. 25.2KB
BNO Recapitalisation Led by Apeiron Investment Group Ltd
02/06/20PRICE SENSITIVE download Created with Sketch. 136.13KB
BNO BNO Extends Cash Runway Through Deferral of Loan Repayments
11/05/20PRICE SENSITIVE download Created with Sketch. 90.85KB
BNO Appendix 4C - quarterly
23/04/20PRICE SENSITIVE download Created with Sketch. 362.26KB
BNO Recruitment Completed in Phase 2 BNC105 / Nivolumab Trial
15/04/20 download Created with Sketch. 171.03KB
BNO Published BNC210 Phase 2b Data, Additional Information
03/04/20PRICE SENSITIVE download Created with Sketch. 191.39KB
BNO Positive Phase 2b Data for BNC210 in GAD Patients Published
02/04/20PRICE SENSITIVE download Created with Sketch. 131.1KB
BNO Completion of Sale of Bionomics' French Subsidiaries
03/03/20PRICE SENSITIVE download Created with Sketch. 117.55KB
BNO Half Yearly Report and Accounts
28/02/20PRICE SENSITIVE download Created with Sketch. 557.33KB
BNO Appendix 4C - quarterly
30/01/20PRICE SENSITIVE download Created with Sketch. 359.22KB
BNO Bionomics Corporate Presentation
29/01/20PRICE SENSITIVE download Created with Sketch. 1.03MB
BNO Lapse of Unlisted Employee Share Options and Warrant
19/12/19 download Created with Sketch. 412.01KB
BNO Sale of French Subsidiaries to Domain Therapeutics
11/12/19PRICE SENSITIVE download Created with Sketch. 118.67KB
BNO Results of Meeting
20/11/19 download Created with Sketch. 97.14KB
BNO Planned Recruitment of New CEO
20/11/19PRICE SENSITIVE download Created with Sketch. 123.75KB
BNO Executive Chairman's 2019 AGM Presentation
20/11/19PRICE SENSITIVE download Created with Sketch. 1.03MB
BNO Bionomics Receives R&D Tax Incentive Refund of $5.1M
11/11/19PRICE SENSITIVE download Created with Sketch. 79.96KB
BNO FDA Grants Fast Track Designation to BNC210 PTSD Program
04/11/19PRICE SENSITIVE download Created with Sketch. 91.11KB
BNO Appendix 4C - quarterly
28/10/19PRICE SENSITIVE download Created with Sketch. 563.09KB
BNO Appendix 4G / Corporate Governance Statement
18/10/19 download Created with Sketch. 447.07KB
BNO Bionomics Annual Report 2019
18/10/19 download Created with Sketch. 2.21MB
BNO Notice of Annual General Meeting/Proxy Form
18/10/19 download Created with Sketch. 1.39MB
BNO BNC210 Solid Dose Achieves Required Blood Levels
26/09/19PRICE SENSITIVE download Created with Sketch. 91.93KB
BNO BNO - FDA Fast Track Application
19/09/19PRICE SENSITIVE download Created with Sketch. 84.66KB
BNO Date of 2019 Annual General Meeting
30/08/19 download Created with Sketch. 25.77KB
BNO Full Year Statutory Accounts
20/08/19 download Created with Sketch. 1.27MB
BNO Bionomics 2018/2019 Preliminary Final Results
20/08/19PRICE SENSITIVE download Created with Sketch. 178.41KB
BNO Appendix 4C - quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 350.71KB
BNO Bionomics Receives Further R&D Tax Incentive Refund of $1.3M
22/07/19PRICE SENSITIVE download Created with Sketch. 81.14KB
BNO Appendix 3B
12/07/19 download Created with Sketch. 408.75KB
BNO Executive Chairman Extension of Appointment
28/06/19 download Created with Sketch. 118.36KB
BNO Presentation - BNC210 Update
26/06/19PRICE SENSITIVE download Created with Sketch. 612.31KB
BNO Results of BNC210 Agitation Trial
26/06/19PRICE SENSITIVE download Created with Sketch. 197.33KB
BNO Trading Halt
24/06/19PRICE SENSITIVE download Created with Sketch. 140.29KB
BNO Appendix 3B
21/06/19 download Created with Sketch. 407.81KB
BNO Ceasing to be a substantial holder
13/06/19 download Created with Sketch. 180.26KB
BNO BNC375 Medicinal Chemistry Paper Published
05/06/19 download Created with Sketch. 114KB
BNO Strategic Review Outcome and Program Updates
29/05/19PRICE SENSITIVE download Created with Sketch. 106.63KB
BNO Results of the PTSD Trial and Exposure Analyses Presented
16/05/19 download Created with Sketch. 94.36KB
BNO Appendix 4C - quarterly
30/04/19PRICE SENSITIVE download Created with Sketch. 344.66KB
BNO Executive Chairman Extension of Appointment
15/03/19 download Created with Sketch. 103.47KB
BNO S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE download Created with Sketch. 175.31KB
BNO Further Analysis of Phase 2 PTSD Trial Results Presentation
18/02/19PRICE SENSITIVE download Created with Sketch. 690.3KB
BNO Further Analysis of Phase 2 PTSD Results
18/02/19PRICE SENSITIVE download Created with Sketch. 136.22KB
BNO Half Yearly Report and Accounts
15/02/19PRICE SENSITIVE download Created with Sketch. 497.57KB
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.